Tag: Mylan
The Need for Clarification on Product Hopping: Open Questions after Namenda...
Posted by Social Science Research Network
The Need for Clarification on Product Hopping: Open Questions after Namenda and Doryx
By Lindsey M. Edwards (Wilson Sonsini Goodrich...
US: EpiPen maker may have overcharged taxpayers by $1.27 billion
Mylan Pharmaceuticals, the maker of EpiPens for allergy sufferers, may have overcharged taxpayers as much as $1.27 billion by misclassifying their life-saving devices under...
US: Noted antitrust attorney to lead nationwide class action suit over...
A federal judge in Kansas has appointed Dallas lawyer Warren T. Burns and two other attorneys to lead a nationwide class action against Mylan...
US: Generics’ motion to dismiss price fixing claims denied
Six drug companies including Mylan NV and Teva Pharmaceuticals have lost a bid to dismiss lawsuits accusing them of engaging in a scheme to...
US: Michigan joins antitrust action against six drug companies
Michigan on Wednesday joined a multi-state antitrust lawsuit against six generic drug companies.
The action by Attorney General Bill Schuette against Heritage Pharmaceuticals and five...
